Transforming surgical productivity
TCC-CASEMIX has the potential to disrupt the secondary care surgical pathway by transforming the way that digital information is gathered, stored and utilised to enhance and optimise the process, from the first consultation to long-term follow up.
TCC-CASEMIX creates a surgical dataset which provides insights into the causal factors of unpredictability of surgical list completions. In so doing it enables a transformation in surgical planning, and becomes a means to make a major impact on surgical waiting lists.
The award winning TCC-CASEMIX is delivered as a cloud-service. It utilises the latest open-standards for data integration, supporting the whole surgical patient pathway from primary care into secondary care, and then back into the community for post-operative care. It is currently deployed at the Northern Care Alliance NHS Group, and since June 2020, it has been deployed at University Hospital Szeged in Hungary.
For the first time there is complete data transparency along the whole surgical pathway. It is this transparency that delivers valuable insights into the effectiveness of patient care and health outcomes.
Every stage of the pathway is measurable because all data is pre-coded according to SNOMED CT. All patient comorbidities are correlated with surgical interventions, medical devices, and ultimately with patient reported outcome measures.
TCC-CASEMIX Analytics creates insights into surgical productivity. For trusts undertaking theatre transformation programmes this data is invaluable for staff training, as detailed metrics for every surgical activity undertaken in the operating theatre are provided.
The system also provides total traceability of medical devices used in their surgery. This was one of the major recommendations of the Cumberlege Review. TCC-CASEMIX manages this need by providing the technology for registries to automatically acquire this data for the trust.
We seek NHS trusts to participate in our on-going research. As a partner, the trust would gain access to the technology [through a research license fee], and through this the trust would obtain unique insights into their surgical productivity.